The White House revealed that the newly negotiated prices could save U.S. taxpayers a staggering $6 billion.
Pfizer
CDC director overrides advisory panel, joins FDA in recommending Pfizer booster for 65+, high-risk
CDC Director Dr. Rochelle Walensky overrode the CDC advisory committee, providing the go-ahead for all groups listed under the FDA’s emergency use authorizations—including those with increased job-site risk.
FDA panel recommends limiting Pfizer booster shots to Americans 65 and older, high risk
The key scientific advisory council of the FDA has voted to deny use of a booster shot of Pfizer’s mRNA vaccine to the general public for the time being.
Moderna vaccine appears to offer the strongest protection against COVID
levels were higher in participants vaccinated with the Moderna vaccine than those who received the Pfizer-BioNTech vaccine or the Janssen vaccine.
What does full FDA approval of a vaccine do if it’s already authorized for emergency use?
All vaccines undergo five stages to ensure their safety and efficacy before approval.
FDA grants full approval to Pfizer vaccine
The Pfizer-BioNTech vaccine has become the first vaccine to be approved by the FDA.
New coronavirus vaccine requires ‘trust’ of African American community
News surrounding Pfizer and BioNTech’s announcement that their coronavirus vaccine was more than 90% effective comes as arrives as the United States continues to realize record-breaking new cases.
